Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    StockNews24StockNews24
    Subscribe
    • Shares
    • News
      • Featured Company
      • News Overview
        • Company news
        • Expert Columns
        • Germany
        • USA
        • Price movements
        • Default values
        • Small caps
        • Business
      • News Search
        • Stock News
        • CFD News
        • Foreign exchange news
        • ETF News
        • Money, Career & Lifestyle News
      • Index News
        • DAX News
        • MDAX News
        • TecDAX News
        • Dow Jones News
        • Eurostoxx News
        • NASDAQ News
        • ATX News
        • S&P 500 News
      • Other Topics
        • Private Finance News
        • Commodity News
        • Certificate News
        • Interest rate news
        • SMI News
        • Nikkei 225 News1
    • Carbon Markets
    • Raw materials
    • Funds
    • Bonds
    • Currency
    • Crypto
    • English
      • العربية
      • 简体中文
      • Nederlands
      • English
      • Français
      • Deutsch
      • Italiano
      • Português
      • Русский
      • Español
    StockNews24StockNews24
    Home » Illumina earnings beat by $0.26, revenue was in line with estimates By Investing.com
    News

    Illumina earnings beat by $0.26, revenue was in line with estimates By Investing.com

    userBy user2024-11-04No Comments1 Min Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    [ad_1]

    Investing.com – Illumina (NASDAQ: ) reported third quarter EPS of $1.14, $0.26 better than the analyst estimate of $0.88. Revenue for the quarter came in at $1.08B versus the consensus estimate of $1.08B.

    Guidance

    Illumina sees Q4 2024 revenue of $1.07B versus the analyst consensus of $950.00M.

    Illumina sees FY 2024 EPS of $4.05-$4.15 versus the analyst consensus of $3.91.

    Illumina’s stock price closed at $153.49. It is up 21.14% in the last 3 months and up 35.08% in the last 12 months.

    Illumina saw 7 positive EPS revisions and 11 negative EPS revisions in the last 90 days. See Illumina’s stock price’s past reactions to earnings here.

    According to InvestingPro, Illumina’s Financial Health score is “fair performance“.

    Check out Illumina’s , and Illumina’s financials here.

    Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar



    [ad_2]

    Source link

    Share this:

    • Share on Facebook (Opens in new window) Facebook
    • Share on X (Opens in new window) X

    Like this:

    Like Loading...

    Related

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleRealty advisors inc sells $290,956 in new concept energy stock By Investing.com
    Next Article 1959 Chevrolet Impala, A Classic Car Fitted With Fuel-Injected V8 Engine
    user
    • Website

    Related Posts

    TGI Group Inc. and AMIRON GROUP Announce Strategic Alliance for Green Digital

    2026-03-12

    Should I buy Rolls-Royce shares after the 9% dip?

    2026-03-12

    This critical stock market indicator’s flashing red! Should investors be worried?

    2026-03-12
    Add A Comment

    Leave a ReplyCancel reply

    © 2026 StockNews24. Designed by Sujon.

    Type above and press Enter to search. Press Esc to cancel.

    %d